Celecoxib
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-845 -
Package NDC
76420-845-01 -
Package NDC
76420-845-05 -
Package NDC
76420-845-07 -
Package NDC
76420-845-14 -
Package NDC
76420-845-20 -
Package NDC
76420-845-30 -
Package NDC
76420-845-60 -
Package NDC
76420-845-90 -
Application number
ANDA205129 -
SPL ID
327a5fba-3c08-7bba-e063-6294a90a75e5 -
SPL set ID
5d0dcac1-237c-47aa-bcfb-50fa20b5b838 -
UNII
JCX84Q7J1L -
RxCUI
205322 -
RxCUI
205323 -
RxCUI
349514 -
RxCUI
686379
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Celecoxib
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Celecoxib",
"splId": "327a5fba-3c08-7bba-e063-6294a90a75e5",
"labels": [
{
"setId": "5d0dcac1-237c-47aa-bcfb-50fa20b5b838",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d0dcac1-237c-47aa-bcfb-50fa20b5b838",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d0dcac1-237c-47aa-bcfb-50fa20b5b838"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 CAPSULE in 1 BOTTLE (76420-845-01)",
"package_ndc": "76420-845-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (76420-845-05)",
"package_ndc": "76420-845-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "7 CAPSULE in 1 BOTTLE (76420-845-07)",
"package_ndc": "76420-845-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "14 CAPSULE in 1 BOTTLE (76420-845-14)",
"package_ndc": "76420-845-14",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "20 CAPSULE in 1 BOTTLE (76420-845-20)",
"package_ndc": "76420-845-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (76420-845-30)",
"package_ndc": "76420-845-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (76420-845-60)",
"package_ndc": "76420-845-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
},
{
"sample": false,
"description": "90 CAPSULE in 1 BOTTLE (76420-845-90)",
"package_ndc": "76420-845-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20240817"
}
],
"productId": "76420-845_327a5fba-3c08-7bba-e063-6294a90a75e5",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "76420-845",
"deaSchedule": null,
"genericName": "Celecoxib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CELECOXIB",
"strength": "400 mg/1"
}
],
"applicationNumber": "ANDA205129",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20201203",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000160",
"M0001335",
"N0000175722"
],
"unii": [
"JCX84Q7J1L"
],
"rxcui": [
"205322",
"205323",
"349514",
"686379"
],
"spl_set_id": [
"5d0dcac1-237c-47aa-bcfb-50fa20b5b838"
],
"pharm_class_cs": [
"Anti-Inflammatory Agents, Non-Steroidal [CS]"
],
"pharm_class_epc": [
"Nonsteroidal Anti-inflammatory Drug [EPC]"
],
"pharm_class_moa": [
"Cyclooxygenase Inhibitors [MoA]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-845_327a5fba-3c08-7bba-e063-6294a90a75e5"